Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis

Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis. In: Pan-American League of Rheumatology Associations (PANLAR) Congress 2018, 07-10 Apr 2018, Buenos Aires, Argentina.

Metadata

Authors/Creators:
  • Helliwell, P
  • Coates, LC
  • FitzGerald, O
  • Nash, P
  • Soriano, ER
  • Husni, ME
  • Hsu, MA
  • Kanik, KS
  • Hendrikx, T
  • Wu, J
  • Kudlacz, E
Dates:
  • Published: April 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 12 Aug 2020 14:14
Last Modified: 12 Aug 2020 14:14
Status: Published
Identification Number: https://doi.org/10.1097/RHU.0000000000000802

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)